Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bruno, C. D. Vizza, A. Ricci, D. Scozzi, M. C. Esposito, E. Cherubini, G. A. Osman, S. Papa, M. Nocioni, M. Mezzapesa, S. Mariotta (Rome, Italy). The dopaminergic system in pulmonary hypertension. Eur Respir J 2013; 42: Suppl. 57, 2643

Member's Comments

No comment yet.

Related content which might interest you: Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary hypertension Source: Eur Respir Monogr 2016; 71: 160-174 Year: 2016 Pulmonary hypertension Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Pulmonary hypertension Source: Course 2015 - Clinical exercise testing Year: 2015 Pulmonary hypertension Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases" Year: 2017 Pulmonary hypertension in obesity-hypoventilation-syndrome Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Pulmonary hypertension Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Pulmonary hypertension Source: Eur Respir Rev 2015; 25: 4-11 Year: 2016 Pulmonary hypertension Source: Eur Respir Mon; 2009: 45: 9–24 Year: 2009 Pulmonary hypertension Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea Year: 2015 Pulmonary hypertension Source: Eur Respir Monogr 2015; 70: 158-170 Year: 2015 Pulmonary hypertension Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 About cardiac output assessment in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Pregnancy and pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012